Shin-Ichi Hirano
Overview
Explore the profile of Shin-Ichi Hirano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ichikawa Y, Sato B, Hirano S, Takefuji Y, Satoh F
Med Gas Res
. 2024 Jul;
14(3):89-95.
PMID: 39073335
The Michael J. Fox Foundation has been funding research on Parkinson's disease for 35 years, but has yet to find a cure. This is due to a problem with the...
2.
Hirano S, Takefuji Y
Biomedicines
. 2024 Jul;
12(7).
PMID: 39062164
While drug therapy plays a crucial role in cancer treatment, many anticancer drugs, particularly cytotoxic and molecular-targeted drugs, cause severe side effects, which often limit the dosage of these drugs....
3.
Sugiyama A, Nakata K, Hirano S, Hasegawa T
Heliyon
. 2024 Mar;
10(6):e27397.
PMID: 38496874
Fluorescent dyes are commonly used as conservative groundwater tracers to track the migration of water. Over- or underestimation of important parameters such as the water flow rate can occur if...
4.
Hirano S, Ichikawa Y, Sato B, Takefuji Y, Satoh F
Med Gas Res
. 2023 Nov;
14(2):84-86.
PMID: 37929512
No abstract available.
5.
Hirano S, Ichikawa Y, Sato B, Takefuji Y, Satoh F
Biomedicines
. 2023 Oct;
11(10).
PMID: 37893190
As diabetes rates surge globally, there is a corresponding rise in the number of patients suffering from diabetic kidney disease (DKD), a common complication of diabetes. DKD is a significant...
6.
Ichikawa Y, Yamamoto H, Hirano S, Sato B, Takefuji Y, Satoh F
Med Gas Res
. 2022 Dec;
13(3):108-111.
PMID: 36571374
Intestinal bacteria can be classified into "beneficial bacteria" and "harmful bacteria." However, it is difficult to explain the mechanisms that make "beneficial bacteria" truly beneficial to human health. This issue...
7.
Okada M, Ogawa H, Takagi T, Nishihara E, Yoshida T, Hyodo J, et al.
Front Neurosci
. 2022 Dec;
16:1024634.
PMID: 36507329
Background: Hydrogen (H) has been reported to be effective in reducing hearing loss due to several causes in animal studies. However, no study has examined the effectiveness of H in...
8.
Hirano S, Ichikawa Y, Sato B, Takefuji Y, Satoh F
Med Gas Res
. 2022 Oct;
13(2):89-91.
PMID: 36204788
Most of the drugs used in modern medical treatments are symptomatic treatments and are far from being a cure for the diseases. The adverse effects are unavoidable in the drugs...
9.
Ichikawa Y, Hirano S, Sato B, Yamamoto H, Takefuji Y, Satoh F
Med Gas Res
. 2022 Oct;
13(2):43-48.
PMID: 36204781
Despite the fact that we have reported on the dangers of the explosion of hydrogen gas inhalers, hydrogen gas inhalers with explosive hazards are, as a matter of fact, still...
10.
Hirano S, Ichikawa Y, Sato B, Takefuji Y, Satoh F
Front Neurol
. 2022 May;
13:841310.
PMID: 35493814
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disorder that is characterized by fatigue that persists for more than 6 months, weakness, sleep disturbances, and cognitive dysfunction. There are multiple possible...